Loading...
Conjugated CBR1 Rabbit mAb

C60267

Conjugated CBR1 Rabbit mAb

Conjugated CBR1 Rabbit mAb (catalogue number C60267) is a recombinant rabbit-derived conjugated primary antibody, reactive with Human samples. It targets Carbonyl reductase [NADPH] 1 (CBR1): NADPH-dependent reductase with broad substrate specificity. Supplied as 100ul at ₪1,627.49; the final price is confirmed on your quote and the lot certificate of analysis ships with the order.

Conjugated Primary AntibodyHostRecombinant RabbitConjugateAF Dye
Host / source
Recombinant Rabbit
Reactivity
Human
Conjugate
AF Dye
UniProt ID
P16152
Gene
CBR1
Target organism
Homo sapiens
Catalogue number
C60267
Brand
LABO Scientific
Storage
Store at 4˚Cin dark for 6 months

Target background

Target: Carbonyl reductase [NADPH] 1 (CBR1) · Homo sapiens

NADPH-dependent reductase with broad substrate specificity. Catalyzes the reduction of a wide variety of carbonyl compounds including quinones, prostaglandins, menadione, plus various xenobiotics. Catalyzes the reduction of the antitumor anthracyclines doxorubicin and daunorubicin to the cardiotoxic compounds doxorubicinol and daunorubicinol. Can convert prostaglandin E to prostaglandin F2-alpha. Can bind glutathione, which explains its higher affinity for glutathione-conjugated substrates. Catalyzes the reduction of S-nitrosoglutathione.

Subcellular location: Cytoplasm

Tissue specificity: Expressed in kidney (at protein level)

Sequence length: 277 aa · 30375 Da

Protein background from UniProtKB, licensed under CC BY 4.0. Describes the target antigen, not this product.

Ordering in Israel

Lead time
Ships from the manufacturer to your lab in 8–14 business days; customs and cold chain handled by LABO Scientific.
Pricing
Quoted in ILS, excl. VAT. Add the item to your quote and we confirm the final price, usually the same business day.
Storage
Store at 4˚Cin dark for 6 months
Documents
Lot certificate of analysis and manufacturer SDS are emailed with your order confirmation.
Who we serve
Universities, hospitals and biotech companies across Israel. Research use only — not for diagnostic or therapeutic use.